If you are not happy with the results below please do another search
“We are excited to add MedLogix to the Citrus Health family,” stated Neil Matheson CEO, Citrus Health Group. ‘Sue and Jeff have built a talented team of scientific communications, medical affairs, and meeting and event professionals and they have an enviable reputation for high quality scientific strategy and excellence in tactical implementation.”
Drugmaker Scynexis said on Monday it would voluntarily recall its antifungal drug Brexafemme from the market and put a temporary hold on studies of the therapy due to the potential risk of cross contamination with another compound.
The collaboration to to discover and develop new treatments for cardiometabolic diseases will leverage human data and artificial intelligence.
In its briefing documents, the agency said it does not believe there is sufficient evidence to support NurOwn’s clinical benefit, adding there were large amounts of missing data.
The agency’s approval offers an alternative to patients who have difficulty taking injections or pills.
Recent drug approvals have shone a light on the role that patient advocacy groups can play in the regulatory process—but some experts have questions about the ethics of this influence.
Despite meeting the primary endpoint and eliciting endoscopic improvements in ulcerative colitis, Morphic Therapeutic’s investigational pill underwhelmed investors with its stock plummeting.
The KlickRx plugin makes it quick and easy to access physician payment information using generative AI.
In a statement, the Drug Regulatory Authority of Pakistan (DRAP) said the health authorities in Punjab, the most populous province, had launched the investigation into the drug Avastin, which is licensed for use in Pakistan.
The development comes after a health ministry panel recommended the drug’s approval in August, followed by standard approval from the U.S. Food and Drug Administration (FDA) in July.
